iCAD releases new CAD version
Computer-aided detection pioneer iCAD has upgraded its mammography CAD technology. The new product, Version 7.2, is now shipping with the company’s workstations SecondLook 300 and 700.
Computer-aided detection pioneer iCAD has upgraded its mammography CAD technology. The new product, Version 7.2, is now shipping with the company's workstations SecondLook 300 and 700.
"It is the latest algorithm that works across our product line," said Jeff Barnes, iCAD senior vice president of sales. "It is the only thing we are shipping now."
A variation of this version is designed for use on FujiFilm Medical USA's CR mammography product, Barnes noted. This particular software, optimized for CR, is still pending FDA approval, however.
CAD v7.2, like preceding versions, automatically identifies and marks areas of a digital mammogram. This latest software, however, has improved sensitivity to subtle cancers with fewer false positives and more understandable indications, according to Dr. Rachel Brem, an early evaluator of the software and director of breast imaging and intervention at the George Washington University Medical Center in Washington, DC.
The company claims CAD v7.2 reduces the number of false markings in SecondLook output. Brem reports that tests at GWU Medical Center showed a significant improvement in mass detection.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
Contrast-Enhanced Mammography Study Reveals 24 Percent Lower Sensitivity with Moderate/Marked BPE
April 30th 2025In comparison to minimal or mild background parenchymal enhancement on contrast-enhanced mammography (CEM), researchers found that moderate or marked BPE was associated with a 12 percent lower AUC for breast cancer detection.
